• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Enforcement Report - Week of August 22, 2012

  • Print
  • Share
  • E-mail
-

Product Detail

Product Description ESTRADIOL 25MG PELLETS 1 PELLET, 15 PEL, 15 PELLET, 2 PELLET, 2 TAB, 3 PELLET, 4 PELLET, 6 PELL, 6 PELLET; ESTRADIOL 50MG PELLETS 1 PELELT, 1 PELLET, 4 PELLET, 6 PELLET; ESTRADIOL CYPIONATE 5MG/ML INJECTABLE 5 ML; ESTRADIOL VALERATE IN COTTONSEED OIL 40 MG/ML INJECTABLE 10 ML; ESTRADIOL VALERATE IN SESAME OIL 40 MG/ML INJECTABLE 10 ML (16 DIFFERENT PRODUCTS)
Recall Number D-1515-2012
Classification Class II
Code Info Rx #'s: 0389464 0398833 0399748 0402917 0402926 0405892 0404079 0404086 0392875 0398067 0403137 0403795 0404506 0408694 0404895 0387492 0389813 0390461 0391264 0391818 0391961 0392952 0393766 0395543 0396232 0396925 0397181 0397313 0397959 0399219 0400227 0400749 0400845 0401497 0401998 0402465 0402997 0403162 0405298 0405330 0405341 0406903 0407419 0408021 0409309 0409791 0402406 0402414 0389982 0389976 0407175 0386101 0391782 0394584 0399576 0403154 0403358 0404795 0406532 0409701 0410127 0400234 0389894 0369509 0407537 0387936 0388504 0401671 0391774 0395019
Product Distributed Qty 72 units
Reason For Recall Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.

Event Detail

Event Id 62416
Product Type Drugs
Status Ongoing
Recalling Firm Franck's Lab Inc., d.b.a. Franck's Compounding Lab
City Ocala
State FL
Country US
Voluntary / Mandated Voluntary: Firm Initiated
Recall Initiation Date 2012-05-25
Initial Firm Notification of Consignee or Public Letter
Distribution Pattern Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies
-
-